A novel anti-HIV strategy uses modified chemokines (intrakines), trapped within the endoplasmic reticulum, to block expression of HIV co-receptors on the host cell surface (pages 1110–1116).
This is a preview of subscription content, log in via an institution to check access.
References
Berger, E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11 (Suppl. A), S3–S16 (1997).
Lusso, P. & Gallo, R.C. Chemokines and HIV infection. Curr. Op. Infect. Dis. 10, 12–17 (1997).
Moore, J.P., Trkola, A. & Dragic, T. Co-receptor for HIV-1 entry. Curr Op. Immunol. 9, 450–468 (1997).
Cohen, J. Exploiting the HIV-chemokine nexus. Science 275, 1261–1264 (1997).
Chen, J.-D. et al. Inactivation of HIV-1 chemokine co-receptor CXCR4 by a novel intrakine strategy. Nature Med. 3, 1110–1116 (1997).
Chen, S.-Y., Bagley, J. & Marasco, W.A. IntraCellular antibodies as a new class of therapeutic molecules for gene therapy. Hum. Gene Ther. 5, 595–601 (1994).
Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877 (1996).
Scarlatti, G. et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. in the press.
Yang, A.-G. et al. Phenotypic knockout of chemokine receptor CCR5 by intrakines as a potential therapeutic approach for HIV-1 infection. Proc. Natl. Acad. Sci USA, in the press.
Cocchi, F. et al. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T Cells. Science 270, 1811–1815 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lusso, P. A chemokine trap for HIV co-receptors. Nat Med 3, 1074–1075 (1997). https://doi.org/10.1038/nm1097-1074
Issue Date:
DOI: https://doi.org/10.1038/nm1097-1074
- Springer Nature America, Inc.